Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

<p>Today's report puts a spotlight on the <strong>Health Care</strong> Sector, which is assuming a global leadership role vs. other Sectors. We also focus on the <strong>Communications </strong>Sector as we are seeing steady relative strength ranking (RSR) improvements over the last couple of months. At the Group level, we highlight select smid-cap <strong>Casinos &amp; Gaming</strong> stocks. Finally, India’s <strong>S&amp;P BSE SENSEX </strong>is breaking out to new all-time highs as RS bullishly inflects, we highlight actionable stocks.</p>

Today's report puts a spotlight on the Health Care Sector, which is assuming a global leadership role vs. other Sectors. We also focus on the Communications Sector as we are seeing steady relative strength ranking (RSR) improvements over the last couple of months. At the Group level, we highlight select smid-cap Casinos &amp; Gaming stocks. Finally, India’s S&amp;P BSE SENSEX is breaking out to new all-time highs as RS bullishly inflects, we highlight actionable stocks.

Global Strategy: Health Care Outperforming - Overweight; India Breaking Out -Add Exposure

Doing bespoke work since 2002....., Custom Products Group

Patrick Hansen

Doing bespoke work since 2002.....

Custom Products Group

Custom Products was started 14 years ago at Lehman Brothers by current co-founder Patrick Hansen, CFA. After 3 years at Lehman, Patrick moved the team to Macquarie Securities where Simon Rigney (co-founder) joined. 3 years ago we took Custom Products independent. 

Our core strength can be summed up three words. 1- Customization - we have very little off the shelf products and most work is done on a one on one bespoke basis. 2- Speed - We pride ourselves in our ability to get requests back to the client very quickly. 3- Confidentiality - We do not redistribute. There is no grace period where we wait a week and then mass blast. Any request stops with that client.

Thematic (Sector/Industry)

<p>With only 2 weeks left in August, we wanted to highlight names that you should be looking at heading into the next couple of months to the end of the year. We screened for names that 1- have a success rate since 2000 greater than 70%. 2- median return relative to TOPIX is greater than 5.5%.</p><h2>Screen Results</h2><figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/031/654/original/2.png?1502826967" class="editor-image img-responsive" data-smartkarma-image-id="31654"></figure><div class="content-caption">Source: Custom Products</div><p>Both <a href="https://www.smartkarma.com/entities/12795" target="_blank" data-smartkarma-citation="entities:12795:1">Yokogawa Electric Corp (6841 JP)</a> and <a href="https://www.smartkarma.com/entities/14085" target="_blank" data-smartkarma-citation="entities:14085:1">Sapporo Holdings Ltd (2501 JP)</a> have been up 88% of the time. That means in the 17 years they have only been down twice relative to…</p>

With only 2 weeks left in August, we wanted to highlight names that you should be looking at heading into the next couple of months to the end of the year. We screened for names that 1- have a success rate since 2000 greater than 70%. 2- median return relative to TOPIX is greater than 5.5%.Screen ResultsSource: Custom ProductsBoth Yokogawa Electric Corp (6841 JP) and Sapporo Holdings Ltd (2501 JP) have been up 88% of the time. That means in the 17 years they have only been down twice relative to…

Which Names Do the Best from September to the End of the Year....

<p>Only  7 names move on more than 2 standard deviations of volume yesterday. <a href="https://www.smartkarma.com/entities/10610" target="_blank" data-smartkarma-citation="entities:10610:1">Alfresa Holdings Corp (2784 JP)</a> topped the list with almost 5 standard deviations of volume.</p><h2>Moved on Volume</h2><figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/025/806/original/2.png?1494440313" class="editor-image img-responsive" data-smartkarma-image-id="25806"></figure><div class="content-caption">Source: Custom Products</div><h2>Moved on News</h2><p>Out of the names that spiked yesterday, only 2 had recent news. <a href="https://www.smartkarma.com/entities/10610" target="_blank" data-smartkarma-citation="entities:10610:1">Alfresa Holdings Corp (2784 JP)</a> was up 2% on massive volume. The only news around Alfresa was that Marathon Asset reported it had lowered its stake. <a href="https://www.smartkarma.com/entities/458" target="_blank" data-smartkarma-citation="entities:458:1">Seibu Holdings Inc (9024 JP)</a> was up 1.2% yesterday and also the only…</p>

Only  7 names move on more than 2 standard deviations of volume yesterday. Alfresa Holdings Corp (2784 JP) topped the list with almost 5 standard deviations of volume.Moved on VolumeSource: Custom ProductsMoved on NewsOut of the names that spiked yesterday, only 2 had recent news. Alfresa Holdings Corp (2784 JP) was up 2% on massive volume. The only news around Alfresa was that Marathon Asset reported it had lowered its stake. Seibu Holdings Inc (9024 JP) was up 1.2% yesterday and also the only…

Leakage Report - 5/10/17 Alfresa Holding up on Almost 5 Standard Deviations of Volume

SGX Market Strategist, Equity & Fixed Income, Singapore Exchange Ltd (SGX)

Geoff Howie

SGX Market Strategist, Equity & Fixed Income

Asia’s leading multi-asset exchange

Singapore Exchange Ltd (SGX)

Singapore Exchange is Asia’s leading and trusted market infrastructure, facilitating the exchange of capital and ideas to create value for people, businesses and economies. As a multi-asset exchange operating equity, fixed income and derivatives markets to the highest regulatory standards, SGX is a vertically integrated business that provides listing, trading, clearing, settlement, depository and data services.

With about 40% of listed companies and over 80% of listed bonds originating outside of Singapore as well as established linkages across the region and in Europe, SGX is Asia’s most international and connected exchange. Offering a full suite of derivatives products across Asian equity indices, commodities and currencies, SGX is the world’s most liquid international market for the benchmark equity indices of China, India, Japan and ASEAN.

As Asia’s pioneering central counterparty, SGX is globally recognised for its risk management and clearing capabilities, and was one of the first globally to adopt the Principles for Financial Market Infrastructure.

Headquartered in AAA-rated Singapore, SGX has over 800 employees including offices in Beijing, Chicago, Hong Kong, London, New York, Mumbai, San Francisco, Shanghai and Tokyo.

<ul><li><strong>From a demand perspective, Asia’s population is growing as is longevity. On the supply side, Asia’s number of doctors, nurses, hospitals and medical equipment diverge across the region, and still trail the per capita averages of the 34 OECD member countries. </strong></li><li><strong>For a shorter-term perspective, over the past five weeks, four Healthcare stocks (Cordlife Group, iX Biopharma, UG Healthcare Corporation &amp; Health Management International) have released Annual Reports whilst a secondary listing (Techcomp Holdings) has released an Interim Report.</strong></li><li><strong>Within these reports, there are examples of how the Healthcare Sector is adapting to Asia Pacific demographics, maintaining an ongoing focus on Research &amp; Development, monitoring pharmaceutical &amp; food regulation trends, collaborating with communities to build business channels, expansion of production lines and pursuing value chain management in manufacturing and distribution.</strong><strong> </strong></li></ul>

From a demand perspective, Asia’s population is growing as is longevity. On the supply side, Asia’s number of doctors, nurses, hospitals and medical equipment diverge across the region, and still trail the per capita averages of the 34 OECD member countries. For a shorter-term perspective, over the past five weeks, four Healthcare stocks (Cordlife Group, iX Biopharma, UG Healthcare Corporation &amp; Health Management International) have released Annual Reports whilst a secondary listing (Techcomp Holdings) has released an Interim Report.Within these reports, there are examples of how the Healthcare Sector is adapting to Asia Pacific demographics, maintaining an ongoing focus on Research &amp; Development, monitoring pharmaceutical &amp; food regulation trends, collaborating with communities to build business channels, expansion of production lines and pursuing value chain management in manufacturing and distribution. 

Japan TMT Analyst

Pelham Smithers

Market Intel on Asian Tech with a Japan focus

Pelham Smithers Associates

Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods. 

Research is provided by the following:
Pelham Smithers: Macro, consumer electronics, telecoms & pharma
Joel Scheiman: Electronics materials / components
Julie Boote: Autos
Will Nestuk: Capital goods, machinery & transportation equipment parts
Thao Nguyen: eCommerce, internet content, marketing & advertising

<p>While it is not a given that a switch from a high growth, high interest rate environment to a low growth, low interest rate environment is a good one for equities in general, it should be good for defensive stocks, because these are the most bond-like of equities and the switch almost defines a fixed income bull market. Japan may not have been particularly high growth or high interest rate in 2000, but it was certainly higher growth and higher interest rate than today, and it is no surprise that defensive sectors like foods (+210% relative to Topix since 1999) and pharmaceuticals (+160%) have done very well over this time.<br><br>The question, now, is whether this is set to continue, or whether we might have hit a turning point.</p>

While it is not a given that a switch from a high growth, high interest rate environment to a low growth, low interest rate environment is a good one for equities in general, it should be good for defensive stocks, because these are the most bond-like of equities and the switch almost defines a fixed income bull market. Japan may not have been particularly high growth or high interest rate in 2000, but it was certainly higher growth and higher interest rate than today, and it is no surprise that defensive sectors like foods (+210% relative to Topix since 1999) and pharmaceuticals (+160%) have done very well over this time.  The question, now, is whether this is set to continue, or whether we might have hit a turning point.

Japan

Alfresa Holdings Corporation is a holding company established through the merger of Azwell Inc. and Fukujin Co., Ltd.  The Company's subsidiaries mainly wholesale and manufacture medical related products including medicines, reagents, and medical tools and equipment.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Alfresa Holdings (2784 JP)

Global Strategy: Health Care Outperforming - Overweight; India Breaking Out -Add Exposure

Today's report puts a spotlight on the Health Care Sector, which is assuming a global leadership role vs. other Sectors. We also focus on...

Vermilion Research

Which Names Do the Best from September to the End of the Year....

With only 2 weeks left in August, we wanted to highlight names that you should be looking at heading into the next couple of months to the end of...

Custom Products Group

Leakage Report - 5/10/17 Alfresa Holding up on Almost 5 Standard Deviations of Volume

Only 7 names move on more than 2 standard deviations of volume yesterday. Alfresa Holdings Corp (2784 JP) topped the list with almost 5 standard...

Custom Products Group

Key Drivers of Asia's Healthcare Sector

From a demand perspective, Asia’s population is growing as is longevity. On the supply side, Asia’s number of doctors, nurses, hospitals and...

Singapore Exchange Ltd (SGX)

Death Rattle for Defensives?

While it is not a given that a switch from a high growth, high interest rate environment to a low growth, low interest rate environment is a good...

Pelham Smithers Associates

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)